75
Participants
Start Date
June 30, 2014
Primary Completion Date
August 31, 2014
Study Completion Date
August 31, 2014
IVACFLU-A/H5N1, 7.5 mcg
Contains 7.5 mcg HA and 0.6 mg of aluminum hydroxide adjuvant per 0.5 mL dose.
IVACFLU-A/H5N1, 15 mcg
Contains 15 mcg HA and 0.6 mg of aluminum hydroxide adjuvant per 0.5 mL dose
Placebo Comparator
PBS, pH 7.2 in 0.5 mL single-dose vials.
Ben Luc Health Center, Bến Lức
Collaborators (1)
Department of Health and Human Services
FED
World Health Organization
OTHER
Institut Pasteur
INDUSTRY
PATH
OTHER
Institute of Vaccines and Medical Biologicals, Vietnam
INDUSTRY